Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results
Janjigian, Yelena Y., Kawazoe, Akihito, Xu, Jianming, Lonardi, Sara, Metges, Jean-Philippe, Wyrwicz, Lucjan S., Shen, Lin, Ostapenko, Yuriy, Bilici, Mehmet, Lowery, Maeve Aine, Valderrama, Adriana, Guan, Yanfen, Li, Kan, Shih, Chie-Schin, Rha, Sun Young
Bu yayın için özet verisi bulunmuyor.
- Dergi
- JOURNAL OF CLINICAL ONCOLOGY
- Yıl
- 2024
- Cilt
- 42
- Sayı
- 3_SUPPL
- Sayfa
- 286-286
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- DOI
- 10.1200/JCO.2024.42.3_suppl.286
- WoS UID
- WOS:001266680500267